Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

pirarubicin MeSH Supplementary Concept Data 2025


MeSH Supplementary
pirarubicin
Unique ID
C027260
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C027260
Entry Term(s)
4'-O-tetrahydropyranyladriamycin
4'-O-tetrahydropyranyldoxorubicin
4'-O-tetrapyranyldoxorubicin
THP-ADM
THP-DOX
THP-adriamycin
THP-doxorubicin
Theprubicin
Théprubicine
pirarubicin hydrochloride
thepirubicin
therarubicin
Pharm Action
Antineoplastic Agents
Registry Numbers
D58G680W0G
E7V83174BE
Related Numbers
72496-41-4
E7V83174BE
CAS Type 1 Name
5,12-Naphthacenedione, 10-((3-amino-2,3,6-trideoxy-4-O-(tetrahydro-2H-pyran-2-yl)-alpha-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, (8S-cis)-
Heading Mapped to
Doxorubicin / analogs & derivatives
Frequency
798
Source
Biotechnol Bioeng 1980;22(suppl 1):83
Indexing Information
Immunosuppressive Agents
Date of Entry
1980/12/12
Revision Date
2017/10/11
pirarubicin Preferred
Théprubicine Narrower
pirarubicin hydrochloride Narrower
therarubicin Narrower
page delivered in 0.01s